Incidence, diagnostic, treatment and outcome of patients diagnosed with cancer of the pancreas during 1986–2009: a population-based study

References

• Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371:1039–1049.
   PubMed Web of Science ®Google Scholar
• Nagenthiraja K, Ewertz M, Engholm G, et al. Incidence and mortality of pancreatic cancer in the Nordic countries 1971–2000. Acta Oncol. 2007;46:1064–1069.
   PubMed Web of Science ®Google Scholar
• Klint Å, Engholm G, Storm H, et al. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol. 2010;49:578–607.
   PubMed Web of Science ®Google Scholar
• Storm HH, Engholm G, Hakulinen T, et al. Survival of patients diagnosed with cancer in the Nordic countries up to 1999–2003 followed to the end of 2006. A critical overview of the results. Acta Oncol. 2010;49:532–544.
   PubMed Web of Science ®Google Scholar
• Arnar DO, Theodors A, Isaksson HJ, et al. Cancer of the pancreas in Iceland. An epidemiologic and clinical study, 1974–85. Scand J Gastroenterol. 1991;26:724–730.
   PubMed Web of Science ®Google Scholar
• Herrmann R, Bodoky G, Ruhstaller T, et al. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol. 2007;25:2212–2217.
   PubMed Web of Science ®Google Scholar
• Sigurdardottir LG, Jonasson JG, Stefansdottir A, et al. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness. Acta Oncol. 2012;51:880–889.
   PubMed Web of Science ®Google Scholar
• Levi F, Lucchini F, Negri E, et al. Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas. 2003;27:139–142.
   PubMed Web of Science ®Google Scholar
• Jonsdottir LS, Jensson V. þróun tóbaksneyslu á Íslandi. Embætti Landlæknis; 2016. ISBN 978-9935-9282-4-5.
   Google Scholar
• Howlader N, Noone AM, Krapcho M. SEER Cancer Statistics Review, 1975–2011; 2016. Available from: http://seer.cancer.gov/archive/csr/1975_2011/
   Google Scholar
• Luo J, Xiao L, Wu C, et al. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004–2009. PLoS One. 2013;8:e76052.
   PubMed Web of Science ®Google Scholar
• Shaib YH, Davila JA, El-Seraq HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther. 2006;24:87–94.
   PubMed Web of Science ®Google Scholar
• Agarwal B, Abu-Hamda E, Molke KL, et al. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol. 2004;99:844–850.
   PubMed Web of Science ®Google Scholar
• DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141:753–763.
   PubMed Web of Science ®Google Scholar
• Baxter NN, Whitson BA, Tuttle TM. Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol. 2007;14:1320–1326.
   PubMed Web of Science ®Google Scholar
• McDowell BD, Chapman CG, Smith BJ, et al. Pancreatectomy predicts improved survival for pancreatic adenocarcinoma: results of an instrumental variable analysis. Ann Surg. 2015;261:740–745.
   PubMed Web of Science ®Google Scholar
• Gudjonsson B. Pancreatic cancer: survival, errors and evidence. Eur J Gastroenterol Hepatol. 2009;21:1379–1382.
   PubMed Web of Science ®Google Scholar
• Lau MK, Davila JA, Shaib YB. Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States. Pancreas. 2010;39:458–462.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hochster H, Stein S, et al. Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity. Exp Hematol Oncol. 2015;4:29.
   PubMed Web of Science ®Google Scholar
• Sharp L, Carsin AE, Cronin-Fenton DPO, et al. Is there under-treatment of pancreatic cancer? Evidence from a population based study in Ireland. Eur J Cancer. 2009;45:1450–1459.
   PubMed Web of Science ®Google Scholar
• Krzyzanowska MK, Weeks JC, Earle CC. Treatment of locally advanced pancreatic cancer in the real world: population based practises and effectiveness. J Clin Oncol. 2003;21:3409–3414.
   PubMed Web of Science ®Google Scholar
• Cress RD, Yin D, Clarke L, et al. Survival among patients with adenocarcinoma of the pancreas: population based-study (United States). Cancer Causes Control. 2006;17:403–409.
   PubMed Web of Science ®Google Scholar
• Yip D, Karapetis C, Strickland A, et al. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev. 2006;19:CD002093.
   Google Scholar
• Linder S, Boström L, Nilsson B. Pancreatic carcinoma incidence and survival in Sweden in 1980-2000: a population-based study of 16758 hospitalized patients with special reference to different therapies. Eur J Surg Oncol. 2007;33:616–622.
   PubMed Web of Science ®Google Scholar
• Cronin-Fenton DP, Erichsen R, Mortensen FV, et al. Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population based cohort study. Clin Epidemiol. 2011;3:19–25.
   PubMedGoogle Scholar
• Hurton S, MacDonald F, Porter G, et al. The current state of pancreatic cancer in Canada: incidence, mortality, and surgical therapy. Pancreas. 2014;43:879–885.
   PubMed Web of Science ®Google Scholar
• Akhtar-Danesh GG, Finley C, Akhtar-Danesh N. Long-term trends in the incidence and relative survival of pancreatic cancer in Canada: a population-based study. Pancreatology. 2016;16:259–265.
   PubMed Web of Science ®Google Scholar